Claybrook Capital, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Claybrook Capital, LLC

  • $172 Million
  • Q3 2023

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$574.03 - $680.96 $494,239 - $586,306
-861 Closed
0 $0
Q2 2021

Jul 26, 2021
BUY
$472.8 - $558.54 $407,080 - $480,902
861 New
861 $480,000
Q1 2019

May 15, 2019
SELL
$372.08 - $439.57 $52,835 - $62,418
-142 Closed
0 $0
Q4 2018

Feb 14, 2019
BUY
$335.82 - $403.04 $47,686 - $57,231
142 New
142 $53,000

Others Institutions Holding REGN

# of Institutions
1,532
Shares Held
82.7M
Call Options Held
1.22M
Put Options Held
1.51M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $78.6B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Claybrook Capital, LLC Portfolio

Follow Claybrook Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Claybrook Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Claybrook Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email